Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

China flag China · Delayed Price · Currency is CNY
7.06
-0.04 (-0.56%)
Mar 9, 2026, 3:00 PM CST
-3.16%
Market Cap 7.18B
Revenue (ttm) 3.78B
Net Income (ttm) 214.11M
Shares Out 1.02B
EPS (ttm) 0.21
PE Ratio 33.60
Forward PE 26.15
Dividend 0.12 (1.69%)
Ex-Dividend Date n/a
Volume 6,869,875
Average Volume 11,298,251
Open 7.01
Previous Close 7.10
Day's Range 6.97 - 7.07
52-Week Range 6.70 - 9.42
Beta 1.36
RSI 35.52
Earnings Date Apr 3, 2026

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the production and sales of pharmaceuticals, raw materials, and additives in China. The company is involved in cosmetics and medicine businesses. It provides cleansers, lotions, creams, essences, masks, and other products. In addition, the company offers dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, and accelerates project research and investigation areas. Further, it serves hospitals, pharmacies, primary medical institutions, and chain drug stores, etc. The company was for... [Read more]

Sector Real Estate
Founded 1993
Employees 3,630
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600223
Full Company Profile

Financial Performance

In 2024, SHA:600223's revenue was 3.98 billion, a decrease of -13.02% compared to the previous year's 4.58 billion. Earnings were 243.53 million, a decrease of -19.73%.

Financial Statements

News

There is no news available yet.